Effect of Target Fortified Human Milk on the Growth Quality of Very Preterm Infants (TargetFort) (TargetFort)
Effect of Target vs. Standard Human Milk Fortification on the Growth and Body Composition of Predominantly Human Milk Fed Very Preterm Infants
Sponsor: Centro Hospitalar de Lisboa Central
Listed as NCT04400396, this observational or N/A phase trial focuses on Adiposity and Body Composition and remains ongoing. Sponsored by Centro Hospitalar de Lisboa Central, it has been updated 9 times since 2020, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Sep 2025 — Present [monthly]
Unknown
-
Sep 2024 — Sep 2025 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status
Status: Enrolling By Invitation → Unknown Status
-
Dec 2021 — Jul 2022 [monthly]
Enrolling By Invitation
▶ Show 4 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Enrolling By Invitation
-
Nov 2020 — Jan 2021 [monthly]
Enrolling By Invitation
-
Jul 2020 — Nov 2020 [monthly]
Enrolling By Invitation
-
Jun 2020 — Jul 2020 [monthly]
Enrolling By Invitation
First recorded
Feb 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Centro Hospitalar de Lisboa Central
- Sociedade Portuguesa de Neonatologia
For direct contact, visit the study record on ClinicalTrials.gov .